CVE-2022-23463

Public Exploit
SpEL Injection in Nepxion Discovery

Description

Nepxion Discovery is a solution for Spring Cloud. Discover is vulnerable to SpEL Injection in discovery-commons. DiscoveryExpressionResolver’s eval method is evaluating expression with a StandardEvaluationContext, allowing the expression to reach and interact with Java classes such as java.lang.Runtime, leading to Remote Code Execution. There is no patch available for this issue at time of publication. There are no known workarounds.

Category

9.4
CVSS
Severity: Critical
CVSS 3.1 •
EPSS 2.38% Top 20%
Third-Party Advisory github.com
Affected: Nepxion Discover
Published at:
Updated at:

References

Link Tags
https://securitylab.github.com/advisories/GHSL-2022-033_GHSL-2022-034_Discovery/ third party advisory exploit

Frequently Asked Questions

What is the severity of CVE-2022-23463?
CVE-2022-23463 has been scored as a critical severity vulnerability.
How to fix CVE-2022-23463?
To fix CVE-2022-23463, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-23463 being actively exploited in the wild?
It is possible that CVE-2022-23463 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-23463?
CVE-2022-23463 affects Nepxion Discover.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.